Waldenström macroglobulinemia is a lymphoplasmacytic lymphoma characterized by the production of monoclonal IgM. The large pentameric structure of IgM molecules leads to a significant increase in serum viscosity, causing hyperviscosity syndrome. The classic symptoms of hyperviscosity syndrome include blurry vision, headaches, confusion, and mucosal bleeding (e.g., epistaxis), as seen in this patient. Multiple myeloma typically involves IgG or IgA and rarely causes hyperviscosity.

A major long-term complication of mantle field radiation (radiation to the mediastinum, neck, and axillae) for Hodgkin lymphoma is radiation-induced cardiovascular disease. This includes premature coronary artery disease, valvular abnormalities, pericardial disease, and cardiomyopathy. These complications can manifest decades after treatment. Therefore, survivors require diligent screening and aggressive management of cardiovascular risk factors.

The t(9;22) translocation results in the BCR-ABL fusion gene, which produces a constitutively active tyrosine kinase that drives the proliferation of granulocytes in Chronic Myeloid Leukemia (CML). Imatinib is a tyrosine kinase inhibitor (TKI) that specifically targets the BCR-ABL protein. TKIs are the standard first-line therapy for chronic phase CML and have dramatically improved prognosis, inducing long-term remissions in the vast majority of patients.

This patient's clinical picture of pancytopenia, massive splenomegaly, a dry bone marrow tap, and characteristic hairy cells on peripheral smear is highly suggestive of hairy cell leukemia. Flow cytometry of peripheral blood to identify characteristic markers (CD11c, CD25, CD103) is the most appropriate next diagnostic step. The dry tap makes bone marrow aspiration difficult, and flow cytometry can establish the diagnosis without invasive procedures.

The development of aggressive symptoms (B symptoms, rapidly enlarging nodes) and a high LDH in a patient with previously indolent CLL is highly concerning for Richter's transformation. This is the transformation of CLL into a high-grade lymphoma, most commonly Diffuse Large B-cell Lymphoma (DLBCL). This transformation carries a very poor prognosis and requires aggressive chemoimmunotherapy.

This patient has symptomatic hyperleukocytosis, a condition known as leukostasis. It is an oncologic emergency caused by the sludging of leukemic blasts in the microvasculature, particularly in the lungs and central nervous system. This leads to hypoxemia and neurologic deficits. The most urgent intervention is to rapidly decrease the circulating blast count, which is most effectively achieved with leukapheresis. Induction chemotherapy is also initiated, but leukapheresis provides a more immediate reduction in cell burden.

The most common cause of acute kidney injury in multiple myeloma is light chain cast nephropathy, also known as myeloma kidney. Excess monoclonal light chains (Bence-Jones proteins) are filtered by the glomerulus and then precipitate within the distal tubules, combining with Tamm-Horsfall protein to form obstructive casts. This leads to tubular damage and renal failure. The discrepancy between the dipstick (which primarily detects albumin) and the 24-hour protein is a classic clue, as the dipstick does not detect light chains well.

The clinical picture of promyelocytes with multiple Auer rods and disseminated intravascular coagulation (DIC) is classic for Acute Promyelocytic Leukemia (APL), which is associated with the t(15;17) translocation. APL is a medical emergency due to the high risk of life-threatening hemorrhage from DIC. The cornerstone of treatment is all-trans-retinoic acid (ATRA), which induces differentiation of the malignant promyelocytes, leading to rapid resolution of the coagulopathy. Treatment with ATRA should be initiated immediately upon suspicion of APL and not delayed for genetic confirmation.